Zosano Pharma Corporation (NASDAQ:ZSAN) fell 2.4% on Friday . The stock traded as low as $0.94 and last traded at $0.97. 295,870 shares traded hands during trading, a decline of 76% from the average session volume of 1,224,250 shares. The stock had previously closed at $0.94.
Separately, ValuEngine raised Zosano Pharma Corporation from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st.
The company’s market cap is $37.27 million. The firm has a 50 day moving average of $0.94 and a 200 day moving average of $1.87.
Zosano Pharma Corporation (NASDAQ:ZSAN) last posted its quarterly earnings data on Thursday, August 10th. The biotechnology company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.02). During the same quarter in the prior year, the business posted ($0.54) EPS. On average, analysts anticipate that Zosano Pharma Corporation will post ($0.85) earnings per share for the current fiscal year.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its stake in Zosano Pharma Corporation by 20.8% in the second quarter. Vanguard Group Inc. now owns 1,217,323 shares of the biotechnology company’s stock valued at $1,716,000 after purchasing an additional 209,251 shares during the period. Endurant Capital Management LP acquired a new position in Zosano Pharma Corporation in the first quarter valued at $1,135,000. Nexthera Capital LP acquired a new position in Zosano Pharma Corporation in the first quarter valued at $950,000. Perceptive Advisors LLC acquired a new position in Zosano Pharma Corporation in the first quarter valued at $950,000. Finally, Victory Capital Management Inc. acquired a new position in Zosano Pharma Corporation in the first quarter valued at $449,000. Institutional investors own 22.66% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.chaffeybreeze.com/2017/09/15/zosano-pharma-corporation-zsan-shares-down-2-4.html.
Zosano Pharma Corporation Company Profile
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Receive News & Ratings for Zosano Pharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma Corporation and related companies with MarketBeat.com's FREE daily email newsletter.